Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 3/20 | 0.40 |
| ▸ | MAOA | P21397 | 2/20 | 0.40 |
| ▸ | G6PD | P11413 | 2/20 | 0.39 |
| ▸ | MIF | P14174 | 1/20 | 0.37 |
| ▸ | APP | P05067 | 3/20 | 0.36 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.35 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.34 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.33 |
| ▸ | AHR | P35869 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 2/20 | 0.33 |
| ▸ | CA2 | P00918 | 2/20 | 0.33 |
| ▸ | NCEH1 | Q6PIU2 | 1/20 | 0.32 |
| ▸ | STS | P08842 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL549183 | 0.88 | G6PD (0.45) | G6PDMIFAPPLIMK1DYRK1A | |
| SCHEMBL23624437 | 0.86 | LIMK1 (0.49) | MAOBMAOALIMK1AHRCA1 | |
| SCHEMBL29644557 | 0.82 | RAB9A (0.41) | MIFAPPDYRK1AAHR | |
| SCHEMBL205544 | 0.82 | RAB9A (0.41) | MIFAPPDYRK1AAHR | |
| SCHEMBL30482454 | 0.81 | EPM2A (0.42) | MAOBMAOAG6PDMIFAPP | |
| SCHEMBL15239483 | 0.81 | EPM2A (0.42) | MAOBMAOAG6PDMIFAPP | |
| SCHEMBL16905520 | 0.79 | GPR3 (0.54) | G6PDMIFAPPCA1CA2 | |
| SCHEMBL18347531 | 0.78 | ALDH1A1 (0.48) | G6PDMIFAPPLIMK1DYRK1A | |
| SCHEMBL24155581 | 0.78 | MIF (0.50) | MAOBMAOAG6PDMIFAPP | |
| SCHEMBL28456601 | 0.77 | G6PD (0.47) | G6PDMIFAPPLIMK1DYRK1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9818951-B2 | Polycyclic compound and organic electronic device comprising the same | LG CHEM, LTD. (KR) | 2017-11-14 | — | — | US | disclosed |
| US-9818951-B2 | Polycyclic compound and organic electronic device comprising the same | LG CHEM, LTD. (KR) | 2017-11-14 | — | — | US | disclosed |
| US-20160329500-A1 | POLYCYCLIC COMPOUND AND ORGANIC ELECTRONIC DEVICE COMPRISING THE SAME | LG CHEM LTD. (KR) | 2016-11-10 | — | — | US | disclosed |
| US-20160329500-A1 | POLYCYCLIC COMPOUND AND ORGANIC ELECTRONIC DEVICE COMPRISING THE SAME | LG CHEM LTD. (KR) | 2016-11-10 | — | — | US | disclosed |
| US-9484539-B2 | Polycyclic compound and organic electronic device comprising the same | LG CHEM, LTD. (KR) | 2016-11-01 | — | — | US | disclosed |
| US-9484539-B2 | Polycyclic compound and organic electronic device comprising the same | LG CHEM, LTD. (KR) | 2016-11-01 | — | — | US | disclosed |
| EP-2876104-A1 | POLYCYCLIC COMPOUND AND ORGANIC ELECTRONIC DEVICE COMPRISING SAME | LG Chem, Ltd. (KR) | 2015-05-27 | — | — | EP | disclosed |
| US-20140151670-A1 | POLYCYCLIC COMPOUND AND ORGANIC ELECTRONIC DEVICE COMPRISING THE SAME | LG CHEM, LTD. (KR) | 2014-06-05 | — | — | US | disclosed |
| US-20140151670-A1 | POLYCYCLIC COMPOUND AND ORGANIC ELECTRONIC DEVICE COMPRISING THE SAME | LG CHEM, LTD. (KR) | 2014-06-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160329500-A1 | POLYCYCLIC COMPOUND AND ORGANIC ELECTRONIC DEVICE COMPRISING THE SAME | PIEZO1, EED, ETV6 | MAOB 2278/4885MAOA 1113/4885G6PD 4729/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.